All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and
Sapanisertib [1224844-38-5]
Referentie T1838-5mg
Formaat : 5mg
Merk : TargetMol
Sapanisertib
(Synonyms: TAK-228, MLN0128, INK 128) Copy Product Info
Sapanisertib (INK 128) is an orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity.
Cas No. 1224844-38-5
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Select Batch
Purity:99.67%
Color:White to Red
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Misschien heeft u ook interesse in de volgende producten:
Referentie
Beschrijving
Cond.
Price Bef. VAT